NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow has been named a 2017 “Luminary” by the Healthcare Businesswomen’s Association (HBA). She will be recognized at the HBA’s 28th Woman of the Year (WOTY) event, held Thursday, May 11, in New York City.
As EVP and chief technology officer, Julie is responsible for the vision and direction of Medidata’s platform and solutions strategy. She leads the part of the organization that designs, develops, delivers and supports the Company’s client-facing products, technology infrastructure and enterprise applications—providing the architecture to help Medidata’s customers and partners accelerate hope for patients on a global scale.
“Julie is the definition of a leader, collaborating closely with her team to help solve some of healthcare’s biggest challenges,” said Mike Capone, Medidata’s chief operating officer. “She is commended for her technological insight, which is enabling the collective life sciences ecosystem to make better decisions from a business, R&D and health outcomes perspective. We’re thrilled that the HBA has recognized her relentless focus on developing and delivering innovation that is transforming clinical development and, ultimately, improving people’s lives.”
Drawing upwards of 2,000 individuals from across the life sciences industry, the May 11th WOTY luncheon celebrates this year’s HBA Luminaries and Rising Stars. The honorees represent professionals in various disciplines and healthcare sectors—including pharmaceutical, biotechnology, advertising, public relations, medical education, scientific discovery, clinical development and market research—who serve as role models in their organizations, actively mentoring others and helping to advance the global healthcare space.
The HBA will also honor this year’s Woman of the Year Bahija Jallal, PhD, executive vice president, AstraZeneca, and head of MedImmune; 2017 Honorable Mentor Joaquin Duato, worldwide chairman, pharmaceuticals, Johnson & Johnson; and 2017 STAR (Strategic Transformation Achievement Recognition) Ceci Zak, principal and COO at Batten & Co (a strategic consulting firm within the Omnicom Group).
Connect with Medidata:
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata chief #tech officer @JulieIskow named a 2017 Luminary by @HBAnet http://ow.ly/UTRz30bBSho #hbaimpact #lifesciences
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About the HBA
The Healthcare Businesswomen’s Association (HBA) is a global not-for-profit organization dedicated to furthering the advancement and impact of women in healthcare worldwide. With 15 chapters throughout the US and in Europe, HBA serves a community of over 30,000 individuals and 100 Corporate Partners. The HBA provides networking forums to build relationships; knowledge sharing and access to thought leaders to broaden perspective; educational programs to develop leadership skills and cutting edge industry knowledge and recognition of outstanding women and companies to promote visibility of their achievements. For more information, visit http://www.hbanet.org.
Medidata is reinventing global drug and medical device development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 850 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world's top 25 global pharmaceutical companies and is used by 16 of the top 20 medical device developers—from study design and planning through execution, management and reporting.